China Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 110 Pages I Mordor Intelligence
China Diabetes Devices Market Analysis
The China diabetes devices market is valued at USD 3.88 billion in 2025 and is projected to reach USD 5.74 billion by 2030, reflecting an 8.18% CAGR. Growth is underpinned by the country's 148 million-strong adult diabetic population in 2024 and by sustained policy support through the Healthy China 2030 program, which prioritizes chronic disease management. Continuous glucose monitoring (CGM) systems are displacing traditional strip-based testing, aided by domestic third-generation sensors that combine accuracy with price advantages. Broader reimbursement for diabetes medicines is spurring parallel demand for monitoring and delivery devices, while digital therapeutics platforms are improving clinical outcomes in underserved regions. Capital investment by multinational and local firms into production and R&D facilities further strengthens the supply base for the China diabetes devices market.
China Diabetes Devices Market Trends and Insights
Rising Diabetes Prevalence and Aging Population
Diabetes prevalence in China rose from below 1% in 1980 to 12.4% in 2018, and cases are projected to climb to 164 million by 2030. Urbanisation, sedentary lifestyles and an expanding older population-over 75% of older adults have at least one chronic disease-continue to enlarge the addressable pool of device users. Annual economic costs are expected to exceed RMB 360 billion within the decade, prompting both public and private investment in efficient monitoring and delivery technologies.
Government Healthcare Reforms and Insurance Coverage Expansion
National Reimbursement Drug List (NRDL) updates in 2024 added 15 diabetes drugs, immediately lowering out-of-pocket costs and stimulating complementary device uptake . Inclusion of dorzagliatin led to sales of RMB 255.9 million in 2024, up 234% year-on-year . Capitation payment pilots in rural counties have improved prescribing standards and redirect financial incentives toward preventive monitoring.
High Out-of-Pocket Costs for Advanced Devices
Continuous glucose monitoring and insulin pump systems remain expensive despite broader reimbursement. Annual medication costs already average RMB 12,186 (USD 1,676) for older diabetics in Beijing, leaving little room for device upgrades . Pump penetration stands at a modest 0.5%, underlining affordability constraints versus developed markets.
Other drivers and restraints analyzed in the detailed report include:
Technological Advancements in Glucose Monitoring and Insulin Delivery / Growing Affordability of Domestic Devices / Limited Patient Education and Training for Device Use /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Monitoring Devices generated 60.21% of revenue in 2024, cementing their status as the backbone of the China diabetes devices market. CGM sales are forecast to jump from RMB 899 million in 2020 to RMB 5.032 billion by 2030, registering an 18.8% CAGR. The China diabetes devices market size for Monitoring Devices therefore expands faster than the overall market, driven by consumer preference for real-time insights and by clinical evidence linking CGM adoption to improved HbA1c. Self-monitoring blood glucose (SMBG) devices remain essential for routine testing, especially in cost-conscious cohorts, but their growth plateaus as CGM costs fall.
Management Devices are set to grow at 9.10% CAGR between 2025 and 2030. Insulin pump penetration is expected to rise from 0.5% to 1.5% by 2030, still below developed-market norms but indicative of latent demand. Foreign brands presently hold more than 70% share, yet local manufacturers have begun integrating Bluetooth connectivity and CGM compatibility into pumps, positioning for quicker gains. In select hospital pilots, pairing sensor-augmented pumps with algorithm-guided dosing cut hypoglycemic episodes by double-digit percentages, further stimulating adoption.
The China Diabetes Devices Market Report is Segmented Into Device Category (Management Devices and Monitoring Devices), End User (Hospital and Clinics, Home-Care Settings, Retail Pharmacies & Diabetes Centers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E-Commerce / Online Pharmacies). The Market Provides the Value (in USD) and (in Units) for the Above-Mentioned Segments.
List of Companies Covered in this Report:
Roche / Abbott Laboratories / Sinocare / Yuwell-Jiangsu Yuyue Medical / Medtronic / Dexcom / Johnson&Johnson / Novo Nordisk / Beckton Dickinson / Ascensia / Arkray / MicroTech Medical / Lepu Medical / Tianjin MinFound Medical / Sanofi /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Diabetes Prevalence and Aging Population in China
4.2.2 Government Healthcare Reforms and Insurance Coverage Expansion
4.2.3 Technological Advancements in Glucose Monitoring and Insulin Delivery
4.2.4 Growing Affordability of Domestic Devices
4.2.5 Increasing Adoption of Digital Health and Telemedicine
4.2.6 Expanding Private and Public Hospital Infrastructure
4.3 Market Restraints
4.3.1 High Out-of-Pocket Costs for Advanced Devices
4.3.2 Limited Patient Education and Training for Device Use
4.3.3 Stringent and Lengthy Regulatory Approval for Novel Devices
4.3.4 Competition from Low-Cost Unregulated Products
4.4 Value / Supply-Chain Analysis
4.5 Regulatory & Technological Outlook
4.6 Porter's Five Forces
4.6.1 Bargaining Power of Suppliers
4.6.2 Bargaining Power of Buyers
4.6.3 Threat of New Entrants
4.6.4 Threat of Substitutes
4.6.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Device Category
5.1.1 Monitoring Devices
5.1.1.1 Self-Monitoring Blood Glucose (SMBG) Devices
5.1.1.1.1 Glucometers
5.1.1.1.2 Test Strips
5.1.1.1.3 Lancets
5.1.1.2 Continuous Glucose Monitoring (CGM) Devices
5.1.1.2.1 Sensors
5.1.1.2.2 Durables (Receivers & Transmitters)
5.1.2 Management Devices
5.1.2.1 Insulin Delivery Devices
5.1.2.1.1 Insulin Pump Devices
5.1.2.1.2 Insulin Disposable Pens
5.1.2.1.3 Insulin Cartridges in Re-usable Pens
5.1.2.1.4 Insulin Syringes & Jet Injectors
5.2 By End User
5.2.1 Hospitals & Clinics
5.2.2 Home-Care Settings
5.2.3 Retail Pharmacies & Diabetes Centers
5.3 By Distribution Channel
5.3.1 Hospital Pharmacies
5.3.2 Retail Pharmacies
5.3.3 E-commerce / Online Pharmacies
6 Market Indicators
6.1 Type-1 Diabetes Population
6.2 Type-2 Diabetes Population
7 Competitive Landscape
7.1 Market Concentration
7.2 Strategic Moves
7.3 Market Share Analysis
7.4 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
7.4.1 Roche Diagnostics
7.4.2 Abbott Laboratories
7.4.3 Sinocare Inc.
7.4.4 Yuwell-Jiangsu Yuyue Medical
7.4.5 Medtronic plc
7.4.6 Dexcom Inc.
7.4.7 Johnson & Johnson (LifeScan)
7.4.8 Novo Nordisk A/S
7.4.9 Becton, Dickinson and Company
7.4.10 Ascensia Diabetes Care
7.4.11 ARKRAY Inc.
7.4.12 MicroTech Medical
7.4.13 Lepu Medical Technology
7.4.14 Tianjin MinFound Medical
7.4.15 Sanofi
8 Market Opportunities & Future Outlook
8.1 White-Space & Unmet-Need Assessment
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.